# FDA Inspection 1155499 - Agilent Technologies, Inc. - September 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/agilent-technologies-inc/c53be518-bab9-4b26-9a4e-995c4b813c4d
Source feed: FDA_Inspections

> FDA Inspection 1155499 for Agilent Technologies, Inc. on September 29, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155499
- Company Name: Agilent Technologies, Inc.
- Inspection Date: 2021-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275852 - 2025-07-17](https://www.keypedia.com/records/fda_inspections/agilent-technologies-inc/7a481356-a707-4447-9fb3-7ea51a05bfc9)
- [FDA Inspection 1113860 - 2019-12-06](https://www.keypedia.com/records/fda_inspections/agilent-technologies-inc/e59e6b95-1002-401b-bf57-38939ecd6dfa)
- [FDA Inspection 1113860 - 2019-12-06](https://www.keypedia.com/records/fda_inspections/agilent-technologies-inc/ffcced16-561c-44a1-9ddd-67cecc18f1ba)
- [FDA Inspection 1010582 - 2017-01-13](https://www.keypedia.com/records/fda_inspections/agilent-technologies-inc/de2d3061-e074-4e07-9f56-6b68d602bd90)
- [FDA Inspection 1010582 - 2017-01-13](https://www.keypedia.com/records/fda_inspections/agilent-technologies-inc/9ab38a3e-1a00-479e-a3b2-bfb0a49840da)

Company: https://www.keypedia.com/companies/agilent-technologies-inc/480d273c-0e5e-44b6-b766-a13ec00b422c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c